Dr. Mooves A&D Officially Begins New Field Study

(FDA Approved De Novo) Validating Impact on Childhood Subclinical Anxiety & Depression

September 1, 2024

New field study launched by Dr. Mooves A&D to measure the app’s impact on childhood subclinical anxiety, depression, and emotional resilience.

Subscribe to our newsletter for the latest news and updates from Dr. Mooves.